Agent acts against mTOR to prevent lesion progression. Oral cancer incidence reduced by 70 to 90 percent. Results are part of increasing evidence of metformin’s protective effect. PHILADELPHIA — New findings published in Cancer Prevention Research, a journal of the American Association...
Sat, Mar 31 2012
Filed under: Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Prevention Research, meeting, 2012 Annual Meeting, AACR Annual Meeting 2012, Dr. J. Silvio Gutkind, oral cancer